West Paces Advisors Inc. Ptc Therapeutics, Inc. Transaction History
West Paces Advisors Inc.
- $408 Billion
- Q3 2024
A detailed history of West Paces Advisors Inc. transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, West Paces Advisors Inc. holds 500 shares of PTCT stock, worth $22,885. This represents 0.0% of its overall portfolio holdings.
Number of Shares
500
Previous 500
-0.0%
Holding current value
$22,885
Previous $15.3 Million
21.32%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PTCT
# of Institutions
221Shares Held
78.1MCall Options Held
144KPut Options Held
58.7K-
Vanguard Group Inc Valley Forge, PA9.13MShares$418 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.89MShares$361 Million0.05% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$356 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$338 Million4.37% of portfolio
-
Armistice Capital, LLC New York, NY7.23MShares$331 Million4.46% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.27B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...